Potiga

Synopsis, Chemistry

DEVELOPMENTS

2 Drug(s) in Development

2 Drug(s) in Development

DOSSIERs // Finished Dosage Forms

29 Dossiers, 4 FDA Orange Book, 17 Europe, 8 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 200MG, TABLET;ORAL - 300MG, TABLET;ORAL - 400MG, TABLET;ORAL - 50MG

RELATED EXCIPIENT COMPANIES

Suppliers, 17 Kerry, 10 Roquette, 10 Sigachi Industries, 10 Corel Pharma Chem, 8 Microlex e.U, 7 Ideal Cures Pvt Ltd, 6 Gangwal Chemicals, 6 Gangwal Healthcare, 6 Seppic, 6 Lonza Capsugel, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 3 Prachin Chemical, 3 Vasa Pharmachem, 3 DFE Pharma, 3 Kima Chemical, 2 The Dow Chemical Company, 1 Ingredion Pharma Solutions, 1 Aeon Procare, 1 Qualicaps, 1 SPI Pharma, 1 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 1 Rochem International Inc, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Pharmatrans-Sanaq, 1 BASF, 1 Pharm-RX Chemical, 1 DKSH, 1 Jai Radhe Sales

EXCIPIENTS BY APPLICATIONS

46 Coating Systems & Additives, 26 Fillers, Diluents & Binders, 24 Controlled & Modified Release, 18 Disintegrants & Superdisintegrants, 13 Direct Compression, 12 Lubricants & Glidants, 11 Thickeners and Stabilizers, 9 Granulation, 7 Film Formers & Plasticizers, 6 Co-Processed Excipients, 5 Empty Capsules, 5 API Stability Enhancers, 4 Taste Masking, 4 Vegetarian Capsules, 3 Emulsifying Agents, 3 Rheology Modifiers, 3 Chewable & Orodispersible Aids, 2 Coloring Agents, 2 Solubilizers, 2 Parenteral, 1 Topical